◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Burning Rock Biotech Limited (BNR) Financial History

Name: Burning Rock Biotech Limited (BNR) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-09-08

Burning Rock Biotech Limited (BNR) operates in the Diagnostics & Research industry and is headquartered in Guangzhou, China with about 667 employees. Its market capitalization is roughly $126 million. In the fiscal year ended 2025-12-31, BNR reported CNY 540M in revenue and (CNY 55M) in net income.

Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services.

Interactive charts & full statements → Open the BNR valuation workbench →

BNR Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	CNY 540M	CNY 516M	CNY 537M	CNY 563M	—
Gross Profit	CNY 403M	CNY 362M	CNY 363M	CNY 380M	—
Operating Income (EBIT)	(CNY 55M)	(CNY 322M)	(CNY 669M)	(CNY 980M)	—
Net Income	(CNY 55M)	(CNY 347M)	(CNY 654M)	(CNY 971M)	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BNR Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Total Revenue	CNY 108M	CNY 126M	CNY 132M	CNY 149M	CNY 133M
Gross Profit	CNY 78M	CNY 99M	CNY 99M	CNY 108M	CNY 97M
Operating Income (EBIT)	(CNY 19M)	(CNY 12M)	(CNY 16M)	(CNY 12M)	(CNY 15M)
Net Income	(CNY 18M)	(CNY 15M)	(CNY 17M)	(CNY 10M)	(CNY 14M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BNR Free Cash Flow History

BNR Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	CNY 820M	CNY 885M	CNY 1.0B	CNY 1.6B	—
Total Liabilities	CNY 285M	CNY 304M	CNY 272M	CNY 429M	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BNR viewer.

Other Companies in Diagnostics & Research

BDSX · Biodesix, Inc. — $281 million
0928 · King International Investment Limited — HK$241 million
XGN · Exagen Inc. — $177 million
IMDX · Insight Molecular Diagnostics Inc. — $131 million
QUCY · Quantum Cyber N.V. — $115 million
MDXH · MDxHealth SA — $68 million
PRPO · Precipio, Inc. — $48 million
NN6 · NanoRepro AG — €21 million

← BNP All “B” companies BNRG →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.